Target intelligence / Profile preview

ANKRD33B antisense RNA 1 (ANKRD33B-AS1)

Target: ANKRD33B-AS1
Molecular classification: Other (lncRNA, long non-coding RNA)

Overview

ANKRD33B antisense RNA 1 (ANKRD33B-AS1) is a long non-coding RNA gene affiliated with the lncRNA (long non-coding RNA) class. There is currently no characterized function, no known role as a drug target, and limited documented biological or disease association. There is no evidence that it is a therapeutic target, nor are there known interacting drugs, mechanisms of action, biomarkers, or safety concerns reported in public gene resources[5][1][3][6].

Biological functions

Unknown

Disease associations

Unknown

Beyond the preview

Go deeper on ANKRD33B antisense RNA 1 (ANKRD33B-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ANKRD33B antisense RNA 1 (ANKRD33B-AS1).

Explore the full profile